Showing results (1491-1500 of 2,186) with videos related to

Sort By:
Pageof 219
Journal for Immunotherapy of Cancer|March 24, 2021
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancerColt Egelston, Weihua Guo, Susan Yost, et al.
International Journal of Immunopathology and Pharmacology|October 19, 2022
Influence of nitric oxide signaling mechanisms in cancerR Ramírez-Patiño, G Avalos-Navarro, L E Figuera, et al.
Archives of Virology|May 15, 2020
A new begomovirus isolated from a potyvirus-infected bean plant causes asymptomatic infections in bean and N. benthamianaNadia Martínez-Marrero, Jesús Aarón Avalos-Calleros, Elizabeth Chiquito-Almanza, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Targeting the Alk4 pathway protects against age-related bone lossDavid E Maridas, Shek M Chim, Kathryn M Burton, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformationEduardo Olmedillas, Roshan R Rajamanickam, Ruben Diaz Avalos, et al.
Virology|April 15, 2011
Toroidal surface complexes of bacteriophage ϕ12 are responsible for host-cell attachmentAlejandra Leo-Macias, Garrett Katz, Hui Wei, et al.
Cancer Letters|May 27, 2026
Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathologyShreya Madan, Sanad M El-Khatib, Asrita Prathigudupu, et al.
Cureus|August 28, 2025
Secondary HIV Cholangiopathy as a Cause of Acute Cholangitis: A Case ReportGuillermo Avalos Gonzalez, Mariana Carolina Gasga Velasco, Paola V Rosales Verduzco, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2006
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimensFlorence Doualla-Bell, Ava Avalos, Bluma Brenner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantationNavin Wadehra, Sherif Farag, Brian Bolwell, et al.
Pageof 219